Heart and Brain Symposium 2018

Why not save a little money? Exclusive discount through QxMD.

Limited Time Offer (Expires June 14, 10AM EDT)

Key takeaways to expect:

Unparalleled meeting on stroke treatment

Learn how stroke and its sub related conditions are considered as an interdisciplinary meeting point for the collaborative work of cardiologists and neurologists.

Outstanding program

Keep you at the forefront in this important new treatment approach with influencers and top experts in Neurology and Cardiology from around the world.

19 hours of Continuing Education

Earn up to 19.25 AMA PRA Category 1 Credit(s)™ and 19.2 contact hours of Continuing Nursing Education (ANCC).

Unparalleled meeting on stroke treatment

Better patient care and treatment results in stroke are now possible if you apply an interdisciplinary approach combining cardio- and neurological knowledge and skills. Learn how at the Heart and Brain Symposium.

  • Describe advances in the detection of atrial fibrillation.
  • Debate stroke risks, prevention and treatment in atrial fibrillation patients.
  • Discuss oral anticoagulation, vascular disease and stroke.
  • Review Patent Foramen Ovale (PFO) and Stroke.
  • Discuss cardioembolic strokes from the primary to the secondary prevention.
  • Address the relationship of embolic stroke of undetermined source with atrial fibrillation.
  • Discuss clinical trials and treatment options for embolic stroke of undetermined source.
  • Debate the association between cognition and the heart.
  • Review clinical cases lacking clear guidelines for cardiologists and neurologists.
  • Apply the most current scientific, clinical, diagnostic and therapeutic advances in the management of atrial fibrillation.

Conference Schedule

Thursday, June 28, 2018
15:00 – 15:20
Welcome Address
Clyde Yancy, Northwestern University, Feinberg School of Medicine, USA
15:20 – 16:50
SYMPOSIUM: ATRIAL FIBRILLATION – DETECTION, ASSESSING THE RISK AND TREATMENT

25%-30% of all ischemic strokes are of cardio-embolic origin where 45% are related to Atrial Fibrillation (AF). Strokes due to AF are devastating ones with high rates of mortality and disability. Therefore, detecting AF, assessing the stroke risk and tailoring the right preventive treatment to an individual patient is extremely important. This session will highlight and discuss all these important issues.

Chairs:
Clyde Yancy, Northwestern University, Feinberg School of Medicine, USA
Shyam Prabhakaran, Northwestern University, USA

16:50 – 17:00

Short break 

17:00 – 18:25
SYMPOSIUM: ATRIAL CARDIOMYOPATHY

Although AF is the widely discussed issue of cardio-embolic strokes other pathological conditions of the left atrium may be important as a source of embolism. This symposium will shed light on the so far “neglected” topic in cardio-embolic stroke.

Chairs:
Jonathan Halperin, Mount Sinai Medical Center, USA
Clifford Kavinsky, Rush University Medical Center, USA

18:25 – 18:30
Short break
18:30 – 19:00
 KEYNOTE LECTURE: THE HEART FAILURE PATIENT WITH STROKE – WHAT IS IMPORTANT, WHAT IS DIFFERENT?

Chairs:
Natan Bornstein, Shaare Zedek Medical Center, Israel
Jonathan Halperin, Mount Sinai Medical Center, USA

19:00
  Opening Ceremony

Followed by a Networking Welcome Reception

Friday, June 29, 2018
08:30 – 09:15
DEBATE SESSION: PFO – WHO TO CLOSE?

Until recently PFO closure by endovascular procedure was not generally recommended. However, recently the results of 2 RTCs (CLOSE and REDUCE) and the long-term follow-up of the RESPECT trial were published. These results will have an impact on the current practice. The question now is not “should we close”? but “who to close”? This will be the scope of this debate.

Moderators:
Robert Hart, Mc Master University, Canada
Clifford Kavinsky, Rush University Medical Center, USA

1st Debater: Brett Cucchiara, University of Pennsylvania, USA
2nd Debater: Richard Smalling, UTHealth and Memorial Hermann Heart and Vascular Institute, USA

09:15 – 10:00
PANEL DISCUSSION: COLLABORATIVE MEDICINE
Moderators:
James Klaas, Mayo Clinic, USA
Christopher Granger, Duke University School of Medicine, USAWolfram Doehner, ESC Council on Stroke; Interdisciplinary Stroke Research Charite, Germany
James Klaas, Assistant Professor of Neurology, Mayo Clinic, Rochester, USA
Carmelo Graffagnino, Duke University School of Medicine, USA
Hooman Kamel, Weill Cornell Medical Center, USA
10:00 – 10:30
Coffee Break, Exhibition & Poster Viewing
10:30 – 12:00
INTERACTIVE CASE DISCUSSION
Moderators:
Frances Caprio, Northwestern University, USA
Milija Mijajlovic, Neurology Clinic, Clinical Center of SerbiaShadi Yaghi, Brown University, USA
MingMing Ning, Harvard Medical School, USA
12:00 – 12:45
DEBATE SESSION

It is greatly accepted that patients with Embolic Stroke of Unknown Source (ESUS) should go on long-term cardiac monitoring in order to detect sub-clinical AF. However, it is still unknown what is the burden of AF that is clinically relevant to trigger treatment with anticoagulants. This debate will highlight the various opinions: “small vs. extensive” is the dilemma that will be discussed.

Moderator:
Farzaneh Sorond, Northwestern University, Feinberg School of Medicine, USA

The Burden of AF to trigger treatment
1st Debater: Jeff Healey, McMaster University, Canada
2nd Debater: Rod Passman, Northwestern Memorial Hospital, USA

12:45 – 14:15
Break, Exhibition & Poster Viewing
14:15 – 14:45
KEYNOTE LECTURE: NAVIGATE ESUS TRIAL: WHAT DID WE LEARN?
Chairs:
Jeffrey Saver, Geffen School of Medicine at UCLA, USA
TBCRobert Hart, McMaster University, Canada
14:45 – 14:50
Short break
14:50 – 16:40
SYMPOSIUM: COGNITION AND THE HEART

Cognitive impairment due to vascular pathology of the brain- Vascular Cognitive Impairment (VCI) is an important issue. Understanding the underlying and the related risk factors of VCI as well as the effect of the heart on VCI may have an impact on prevention and treatment of this condition. This symposium will discuss this issue from various aspects.

Chairs:
Philip Gorelick, Thorek Memorial Hospital, USA
Georgios Tsivgoulis, University of Athens, Greece

The Neurovascular Unit and Cognitive Impairment
Constantino Iadecola, Feil Family Brain and Mind Research Institute, USA
Hypertension, Small Vessel Disease and Cognition
Ralph Sacco, Miller School of Medicine, University of Miami, USA
Defining Optimal Brain Health in Adults
Philip Gorelick, Mercy Health Hauenstein Neuroscience Center, USA
Aortic Stenosis, TAVR and Cognition: Imaging and Clinical Findings
Ronald Lazar, University of Alabama at Birmingham, USA
Panel Discussion

16:40 – 17:10
Coffee Break, Exhibition & Poster Viewing
17:10 – 18:40
SYMPOSIUM: EMBOLIC STROKE OF UNDETERMINED SOURCE

Stroke due to ESUS imposes difficult clinical dilemma for the treating physician. The magnitude of the problem, practical evaluation and treatment options will be discussed in this symposium.

Chairs:
Ralph Sacco, Miller School of Medicine, University of Miami, USA
Rod Passman, Northwestern Memorial Hospital, USA

The Magnitude of the Problem
Georgios Tsivgoulis, University of Athens School of Medicine/The University of Tennessee Health Science Center, Greece/USA
Evaluation of Patients with ESUS
Jeffrey Saver, Geffen School of Medicine at UCLA, USA
Treatment options
Gustavo Saposnik, University of Toronto, Canada
Panel Discussion

Saturday, June 30, 2018
08:00-09:00
EDUCATIONAL SESSION: BRAIN RECOVERY AFTER STROKE
Chair:
Natan Bornstein, Shaare Zedek Medical Center, Israel
Medical Therapy for Post-Stroke Motor Recovery
Natan Bornstein, Shaare Zedek Medical Center, Jerusalem, Israel
Intracardiac Hemostasis Parameters, Endothelial Damage and Their Association with Microembolization in the Fibrillating Atrium
Laszlo Csiba,University Debrecen, Hungary
Neuroprotection in the Reperfusion Era
Jeffrey Saver, Geffen School of Medicine at UCLA, USA
09:00 – 10:30
SYMPOSIUM: ATRIAL FIBRILLATION: MISCELLANEOUS

There are several practical aspects in the treatment of AF patients with AC. This session will deal with three of these important topics as listed below.

Chair:
Jose Biller, Loyola University Medical Center, USA
TBC

How to Improve the Use of Anticoagulation for Stroke Prevention in AF
Christopher Granger, Duke University School of Medicine, USA
When to Start Anticoagulation after Acute Ischemic Stroke
Natan Bornstein, Shaare Zedek Medical Center, Jerusalem, Israel
Treatment of Acute Stroke in AF Patients with Mechanical Thrombectomy
Gregory Albers, Stanford Stroke Center, USA
Panel Discussion

10:30 – 11:00
Coffee Break, Exhibition & Poster Viewing
11:00 – 11:30
KEYNOTE LECTURE: ATRIAL FIBRILLATION AND STROKE: THE FIRST 100 YEARS
Chairs:
Gregory Albers, Stanford Stroke Center, USA
Wolfram Doehner, Berlin Center for Regenerative Therapies (BCRT), Germany
Robert Hart, McMaster University, Canada
11:30 – 13:00
INTERACTIVE CASE DISCUSSION
Moderator:
Laszlo Csiba, University Debrecen, Hungary
TBCKevin Sheth, Yale School of Medicine, USA
Eitan Auriel, Carmel Medical Center, Israel
13:00 – 14:00
Break, Exhibition & Poster Viewing
14:00 – 15:50
SYMPOSIUM: AF AND ICH

Anticoagulants (AC) are the treatment of choice for stroke prevention in AF patients. However, AC carries a risk of bleeding and especially of Intra-Cerebral Hemorrhage (ICH). Therefore, stroke prevention, acute stroke treatment of AF patients with Mechanical Thrombectomy and when to resume AC after ICH is of a major concern for the treating physician. This symposium will try to clarify these complex and problematic issues.

Chairs:
Mahmut Edip Gurol, Massachusetts General Hospital Harvard Medical School, USA
James Conners, Rush University Medical Center, USA

Stroke Prevention in AF patients at High ICH Risk – Definition and Problems with Medical Management
Edip Gurol, Harvard Medical School, USA
Reversal Agents
John Eikelboom, McMaster University, Canada
Perils of Combination Anticoagulant and Antiplatelet Therapy
Edip Gurol, Harvard Medical School, USA
Resuming Anticoagulation after ICH
Larry Goldstein, University of Kentucky, USA

Panel Discussion

16:00
CLOSING CEREMONY

Speakers Include

Prof. Natan Bornstein, MD

Heart & Brain Chairperson
Shaare Zedek Medical Center, Israel

Wolfram Doehner

ESC Council on Stroke
Univ.-Prof. for Interdisciplinary Stroke Research Charite, Germany

Prof. Christopher Granger, MD, FACC, FAHA

Duke University School of Medicine, Cardiology
USA

Prof. Jonathan Halperin, MD, FACC, FACP, FAHA, MSVM

Mount Sinai Medical Center, Director of Clinical Cardiology
USA

Robert Hart

McMaster University,
Canada

Prof. Ayrton Massaro, MD

Hospital Sirio Libanes, Head of Neurovascular Research Unit
Brazil

Prof. Ralph L. Sacco, MD, MS, FAHA, FAAN, FANA

Miller School of Medicine, University of Miami, Chairman & Professor Department of Neurology
USA

Prof. Jeffrey Saver, MD, FAHA, FAAN, FANA

Geffen School of Medicine at UCLA, Director of the Stroke Unit
USA

Event Pricing

Fees apply to payments received prior to the indicated deadlines.

*Resident & Student/ Nurse/ Advanced Practice Provider & Care Team: In order to benefit from the special fee, a submission of your status confirmation (approval letter signed by the Head of Department or copy of your status ID) must be uploaded during the Online registration.

FEES FOR ALL CONFERENCE PARTICIPANTS INCLUDE:
• Admission to all scientific sessions and poster area
• Admission to the commercial exhibition
• An invitation to the Welcome Reception
• Congress Printed Materials
• Certificate of attendance
• Refreshments during coffee breaks as specified in the program

QxMD is proud to be partnered with this conference to bring you discounted tickets.

Heart and Brain Symposium 2018

June 28-30, 2018Hyatt Regency McCormick Place, Chicago, Illinois, United States

Why not save a little money? Exclusive discount through QxMD.

Limited Time Offer (Expires June 14, 10AM EDT)